|
ZNF791 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.19469999740829E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.41600000006059E-08 |
| Normal-vs-Stage2 |
8.875900E-03 |
| Normal-vs-Stage3 |
5.955000E-04 |
| Normal-vs-Stage4 |
1.847530E-02 |
| Stage1-vs-Stage2 |
4.438200E-01 |
| Stage1-vs-Stage3 |
7.937400E-01 |
| Stage1-vs-Stage4 |
9.837600E-01 |
| Stage2-vs-Stage3 |
6.533800E-01 |
| Stage2-vs-Stage4 |
6.066000E-01 |
| Stage3-vs-Stage4 |
8.636600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.09429999798294E-08 |
| Normal-vs-AfricanAmerican |
2.30399999999742E-05 |
| Normal-vs-Asian |
1.91530000004381E-06 |
| Caucasian-vs-AfricanAmerican |
6.656400E-01 |
| Caucasian-vs-Asian |
4.237500E-03 |
| AfricanAmerican-vs-Asian |
2.203300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.05659997312802E-09 |
| Normal-vs-Female |
9.417500E-03 |
| Male-vs-Female |
6.860000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.92014000000018E-05 |
| Normal-vs-Extreme_Weight |
3.28789995229783E-09 |
| Normal-vs-Obese |
7.170600E-04 |
| Normal-vs-Extreme_Obese |
1.215950E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.438800E-01 |
| Normal_Weight-vs-Obese |
1.823600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.134000E-01 |
| Extreme_Weight-vs-Obese |
1.623640E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.465800E-01 |
| Obese-vs-Extreme_Obese |
2.372600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.164300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.99690000000686E-05 |
| Normal-vs-Age(61-80Yrs) |
2.91409996133751E-09 |
| Normal-vs-Age(81-100Yrs) |
2.72530000000604E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.667200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.790640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.759600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.894080E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.337900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.063600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.52139999989964E-08 |
| Normal-VS-Type2 PRCC |
1.47910000025675E-07 |
| Normal-VS-KIRP CIMP |
3.045800E-01 |
| Normal-VS-Unclassified PRCC |
8.432200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.895000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.090600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.810000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.779700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.914000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.972800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.68760014243696E-10 |
| Normal-vs-N1 |
4.164000E-02 |
| Normal-vs-N2 |
2.883700E-03 |
| N0-vs-N1 |
4.593500E-02 |
| N0-vs-N2 |
9.793400E-01 |
| N1-vs-N2 |
3.928600E-01 |
|
|
